Owing to the contribution of these genes to nicotine pharmacology, CYP2A6 and CHRNA5-A3-B4 increase lung cancer risk indirectly through increased cigarette consumption and thus increased carcinogen exposure. This evidence concerns the gene CHRNA5 and lung cancer.